Glucocorticoid Over-Replacement (Iatrogenic Cushing's Syndrome)
This patient's presentation of central weight gain (upper legs and abdomen), abdominal bruising, and 10+ pound weight gain strongly suggests glucocorticoid over-replacement causing iatrogenic Cushing's syndrome, and the glucocorticoid dose must be reduced immediately to the lowest physiologic replacement range.
Clinical Assessment
The constellation of findings is classic for excess glucocorticoid exposure:
- Central adiposity (abdomen and upper thighs)
- Easy bruising (thin skin from glucocorticoid excess)
- Significant weight gain (>10 lbs)
These are hallmark signs of iatrogenic Cushing's syndrome from over-replacement 1. The post-RNY status is relevant because altered absorption may have led to dose adjustments that are now excessive, or the patient may be on long-acting synthetic glucocorticoids (prednisolone, dexamethasone) which are associated with more adverse effects 1.
Immediate Management Algorithm
Step 1: Assess Current Glucocorticoid Regimen
- Identify the specific glucocorticoid being used (hydrocortisone, prednisolone, or dexamethasone)
- Document total daily dose and timing
- Long-acting synthetic glucocorticoids are more likely to cause these complications 1
Step 2: Reduce to Physiologic Replacement
For hydrocortisone: Reduce to 15-25 mg/day total in 2-3 divided doses 1, 2
- Typical regimen: 10 mg upon waking, 5 mg early afternoon, 2.5-5 mg late afternoon
- First dose should be taken as soon as possible after waking 2, 3
If on prednisolone or dexamethasone: Switch to hydrocortisone immediately 1
- Hydrocortisone is preferred because synthetic glucocorticoids with longer half-lives cause unfavorable nighttime activity and more adverse effects 1
- Conversion: Hydrocortisone 20 mg ≈ Prednisolone 5 mg 4
Step 3: Monitor for Under-Replacement
After dose reduction, watch for signs of inadequate replacement:
- Lethargy, nausea, poor appetite
- Weight loss
- Increased pigmentation (uneven distribution) 2
Critical caveat: Do NOT reduce below the lower end of physiologic replacement (15 mg hydrocortisone daily) as this risks adrenal crisis 5
Post-RNY Considerations
The Roux-en-Y anatomy may affect glucocorticoid absorption, but this typically requires lower doses due to altered first-pass metabolism, not higher doses 6. The weight gain pattern here is inconsistent with post-bariatric weight regain (which occurs gradually over years) 7, 8 and instead matches the rapid, central distribution of glucocorticoid excess.
Verify Mineralocorticoid Replacement
- Fludrocortisone dose should be 0.05-0.2 mg/day 1, 2
- Check for signs of over-replacement: hypokalemia, hypertension, edema 9
- Hydrocortisone has mineralocorticoid activity; prednisolone has reduced activity; dexamethasone has none 1
Monitoring Strategy
Clinical monitoring is the primary tool 2, 10:
- Weight, blood pressure, energy levels
- Examine for signs of over-replacement: bruising, thin skin, edema, hypertension, hyperglycemia 4
- ACTH and cortisol levels are NOT useful for dose adjustment in established Addison's disease 2, 9
Reassess every 2-4 weeks until symptoms resolve and weight stabilizes.
Common Pitfalls to Avoid
Do not use long-acting synthetic glucocorticoids (prednisolone, dexamethasone) for chronic replacement—these are associated with significantly more adverse effects including weight gain, bruising, and metabolic complications 1
Do not over-correct—reducing below physiologic replacement risks adrenal crisis. The goal is 15-25 mg hydrocortisone daily, not lower 1, 2, 10
Do not rely on biochemical markers for dose titration in established Addison's disease—clinical assessment is superior 2, 9
Ensure patient education on stress dosing remains intact during dose adjustment 9, 10
Expected Outcomes
With appropriate dose reduction to physiologic replacement:
- Weight should stabilize within weeks to months
- Bruising should improve as skin integrity recovers
- Central adiposity should gradually resolve
- Quality of life should improve as excess glucocorticoid effects reverse 1
The evidence is clear that excess glucocorticoid replacement causes multiple morbidities, increased mortality, and reduced quality of life 1, making immediate dose optimization essential for this patient's long-term health outcomes.